LEP and obesity disorder: demonstrated that obesity led to accelerated immune aging, tumor advancement, and impaired T cell function mediated by PD-1, driven largely by leptin, while also enhancing the effectiveness of PD-1/PD-L1 blockade in both in vivo models and cancer patients (155).